Details for New Drug Application (NDA): 022305
✉ Email this page to a colleague
NDA 022305 describes PUR-WASH, which is a drug marketed by Niagara Pharms and is included in one NDA. It is available from sixteen suppliers. Additional details are available on the PUR-WASH profile page.
The generic ingredient in PUR-WASH is purified water. There are forty-nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the purified water profile page.
The generic ingredient in PUR-WASH is purified water. There are forty-nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the purified water profile page.
Summary for 022305
| Tradename: | PUR-WASH |
| Applicant: | Niagara Pharms |
| Ingredient: | purified water |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 022305
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PUR-WASH | purified water | SOLUTION;OPHTHALMIC | 022305 | NDA | Acme United Corporation | 0924-0158 | 0924-0158-16 | 473 mL in 1 BOTTLE, UNIT-DOSE (0924-0158-16) |
| PUR-WASH | purified water | SOLUTION;OPHTHALMIC | 022305 | NDA | Acme United Corporation | 0924-0158 | 0924-0158-32 | 946 mL in 1 BOTTLE, UNIT-DOSE (0924-0158-32) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION;OPHTHALMIC | Strength | 98.3% | ||||
| Approval Date: | Sep 1, 2011 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
